PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

BIOMETRICS, published by WILEY, stands as a prestigious journal that has made substantial contributions across diverse fields, including Agricultural and Biological Sciences, Applied Mathematics, and Biochemistry. With an impressive track record from its inception in 1946 and continuing through to 2024, this journal is recognized for its rigorous peer-reviewed research and high-impact findings, evidenced by its Q1 ranking in various categories such as Medicine and Statistics. Researchers and professionals alike will find a wealth of knowledge within its pages, making it an essential resource for anyone involved in these dynamic and evolving disciplines. While BIOMETRICS does not offer open access, its reputation for delivering high-quality research ensures its continued importance in advancing the scientific ecosystem. For those seeking to stay ahead in their fields, engaging with the latest studies published in this journal is indispensable.

Translational and Clinical Pharmacology, published by KSCPT, is an esteemed journal that serves as a vital source of knowledge in the field of pharmacology, particularly focusing on the translational aspects that bridge laboratory research and clinical applications. Established in 2014, this journal aims to disseminate high-quality research and reviews pertaining to drug development, therapeutics, and the underlying mechanisms of action in the medical realm. With an ISSN of 2289-0882 and an E-ISSN of 2383-5427, it holds a significant position with a Q3 ranking in the pharmacology category as of 2023, emphasizing its role in advancing scientific understanding within this crucial discipline. While it operates as a traditional subscription-based journal, its output remains accessible through various academic platforms, contributing to the global discourse in pharmacology. Researchers, professionals, and students will find value in its insightful articles and comprehensive studies, underscoring the journal’s commitment to enhancing pharmacological knowledge and practice.

CLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.

CPT-Pharmacometrics & Systems Pharmacology, published by WILEY, is a leading open access journal dedicated to advancing the fields of pharmacometrics and systems pharmacology. Since its inception in 2012, it has established itself as a vital resource for researchers and practitioners, boasting a remarkable impact factor and occupying prestigious Q1 quartiles in categories such as Cardiology and Cardiovascular Medicine, Modeling and Simulation, and Pharmacology (Medical). The journal covers a broad spectrum of topics aimed at enhancing the understanding of drug development, efficacy, and patient safety through innovative modeling and simulation approaches. With its consistent ranking in the top tiers of its field, CPT-Pharmacometrics & Systems Pharmacology provides invaluable insights and fosters scholarly dialogue among its audience, including researchers, educators, and students. The journal is accessible to all, promoting knowledge dissemination and collaborative growth in the pharmacology community.

Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.

BIOSTATISTICS is a premier academic journal dedicated to the intersection of statistical methodologies and their applications in the field of biomedicine, published by Oxford University Press. With its ISSN 1465-4644 and E-ISSN 1468-4357, the journal has established itself as a crucial resource for researchers and professionals in the broad disciplines of statistics and probability, particularly within medical contexts. The journal proudly holds a Q1 ranking in multiple categories as of 2023, including Medicine (miscellaneous), Statistics and Probability, as well as Statistics, Probability, and Uncertainty, placing it at the forefront of statistical research. It has also achieved notable Scopus rankings, underscoring its influence and reach—ranking 27th in Mathematics (Statistics and Probability) and 94th in Medicine (General Medicine). Although it does not currently offer open access options, BIOSTATISTICS remains committed to advancing scholarly conversation and innovation in statistical science, making it an essential outlet for both established and emerging researchers. With contributions spanning from 2003 to 2024, this journal is actively seeking to foster an understanding of complex statistical approaches in biomedicine, enabling professionals in the field to apply robust statistical techniques to real-world problems.

The Journal of Statistical Theory and Practice is a premier publication dedicated to disseminating cutting-edge research and methodologies within the fields of statistics and probability. Published by Springer, this journal plays a crucial role in advancing the discipline by providing a platform for both theoretical and applied statistical research. With an ISSN of 1559-8608 and an E-ISSN of 1559-8616, the journal has established itself as a notable contributor to academic discourse since its inception in 2007. It offers insights that are essential for researchers, professionals, and students, fostering a deeper understanding of statistical applications across various domains. Despite its current Q3 ranking in Statistics and Probability, the journal is poised for growth, supporting the academic community with open access options and an aim to bridge the gap between statistical theory and everyday practice. By continuing to curate high-quality research, the Journal of Statistical Theory and Practice is committed to enriching the field and encouraging innovative statistical methodologies up until its envisaged convergence in 2024.

Statistics in Biosciences is a distinguished journal published by Springer, focusing on the innovative interplay between statistical methodologies and biosciences. Established in 2009, this journal aims to provide a platform for the dissemination of cutting-edge research in statistical applications within biochemistry, genetics, and molecular biology. With an impressive impact factor and a distinguished ranking in multiple categories, including Q2 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q3 in Statistics and Probability, it serves as a crucial resource for researchers, professionals, and students seeking to deepen their understanding of statistical applications in biological contexts. The journal is accessible through traditional subscription models, ensuring that high-quality research remains available to a wide audience. Featuring contributions that advance statistical theory and application in the biosciences, Statistics in Biosciences is committed to fostering collaboration and innovation in a rapidly evolving scientific landscape.